Literature DB >> 29103086

A Novel Public MR Image Dataset of Multiple Sclerosis Patients With Lesion Segmentations Based on Multi-rater Consensus.

Žiga Lesjak1, Alfiia Galimzianova2, Aleš Koren3, Matej Lukin3, Franjo Pernuš2, Boštjan Likar4, Žiga Špiclin2.   

Abstract

Quantified volume and count of white-matter lesions based on magnetic resonance (MR) images are important biomarkers in several neurodegenerative diseases. For a routine extraction of these biomarkers an accurate and reliable automated lesion segmentation is required. To objectively and reliably determine a standard automated method, however, creation of standard validation datasets is of extremely high importance. Ideally, these datasets should be publicly available in conjunction with standardized evaluation methodology to enable objective validation of novel and existing methods. For validation purposes, we present a novel MR dataset of 30 multiple sclerosis patients and a novel protocol for creating reference white-matter lesion segmentations based on multi-rater consensus. On these datasets three expert raters individually segmented white-matter lesions, using in-house developed semi-automated lesion contouring tools. Later, the raters revised the segmentations in several joint sessions to reach a consensus on segmentation of lesions. To evaluate the variability, and as quality assurance, the protocol was executed twice on the same MR images, with a six months break. The obtained intra-consensus variability was substantially lower compared to the intra- and inter-rater variabilities, showing improved reliability of lesion segmentation by the proposed protocol. Hence, the obtained reference segmentations may represent a more precise target to evaluate, compare against and also train, the automatic segmentations. To encourage further use and research we will publicly disseminate on our website http://lit.fe.uni-lj.si/tools the tools used to create lesion segmentations, the original and preprocessed MR image datasets and the consensus lesion segmentations.

Entities:  

Keywords:  Clinical image dataset; Gold standard; Image segmentation; Intra- and inter-rater variability; White matter lesion

Mesh:

Year:  2018        PMID: 29103086     DOI: 10.1007/s12021-017-9348-7

Source DB:  PubMed          Journal:  Neuroinformatics        ISSN: 1539-2791


  23 in total

1.  Reproducibility of brain MRI lesion volume measurements in multiple sclerosis using a local thresholding technique: effects of formal operator training.

Authors:  M Rovaris; M A Rocca; M P Sormani; G Comi; M Filippi
Journal:  Eur Neurol       Date:  1999       Impact factor: 1.710

Review 2.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

3.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

4.  Brain atrophy and lesion load predict long term disability in multiple sclerosis.

Authors:  Veronica Popescu; Federica Agosta; Hanneke E Hulst; Ingrid C Sluimer; Dirk L Knol; Maria Pia Sormani; Christian Enzinger; Stefan Ropele; Julio Alonso; Jaume Sastre-Garriga; Alex Rovira; Xavier Montalban; Benedetta Bodini; Olga Ciccarelli; Zhaleh Khaleeli; Declan T Chard; Lucy Matthews; Jaqueline Palace; Antonio Giorgio; Nicola De Stefano; Philipp Eisele; Achim Gass; Chris H Polman; Bernard M J Uitdehaag; Maria Jose Messina; Giancarlo Comi; Massimo Filippi; Frederik Barkhof; Hugo Vrenken
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-23       Impact factor: 10.154

5.  Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques.

Authors:  J Grimaud; M Lai; J Thorpe; P Adeleine; L Wang; G J Barker; D L Plummer; P S Tofts; W I McDonald; D H Miller
Journal:  Magn Reson Imaging       Date:  1996       Impact factor: 2.546

6.  Comparison of 3D cube FLAIR with 2D FLAIR for multiple sclerosis imaging at 3 Tesla.

Authors:  M Patzig; M Burke; H Brückmann; G Fesl
Journal:  Rofo       Date:  2013-12-17

Review 7.  Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging.

Authors:  Daniel García-Lorenzo; Simon Francis; Sridar Narayanan; Douglas L Arnold; D Louis Collins
Journal:  Med Image Anal       Date:  2012-09-29       Impact factor: 8.545

8.  Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and Fusion.

Authors:  M Jorge Cardoso; Marc Modat; Robin Wolz; Andrew Melbourne; David Cash; Daniel Rueckert; Sebastien Ourselin
Journal:  IEEE Trans Med Imaging       Date:  2015-04-14       Impact factor: 10.048

Review 9.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.

Authors:  Stéphanie Debette; H S Markus
Journal:  BMJ       Date:  2010-07-26

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  6 in total

1.  Predicting conversion from clinically isolated syndrome to multiple sclerosis-An imaging-based machine learning approach.

Authors:  Haike Zhang; Esther Alberts; Viola Pongratz; Mark Mühlau; Claus Zimmer; Benedikt Wiestler; Paul Eichinger
Journal:  Neuroimage Clin       Date:  2018-11-05       Impact factor: 4.881

2.  High-dimensional detection of imaging response to treatment in multiple sclerosis.

Authors:  Baris Kanber; Parashkev Nachev; Frederik Barkhof; Alberto Calvi; Jorge Cardoso; Rosa Cortese; Ferran Prados; Carole H Sudre; Carmen Tur; Sebastien Ourselin; Olga Ciccarelli
Journal:  NPJ Digit Med       Date:  2019-06-10

Review 3.  Deep Learning in Large and Multi-Site Structural Brain MR Imaging Datasets.

Authors:  Mariana Bento; Irene Fantini; Justin Park; Leticia Rittner; Richard Frayne
Journal:  Front Neuroinform       Date:  2022-01-20       Impact factor: 4.081

4.  Lesion Volume Quantification Using Two Convolutional Neural Networks in MRIs of Multiple Sclerosis Patients.

Authors:  Marcela de Oliveira; Marina Piacenti-Silva; Fernando Coronetti Gomes da Rocha; Jorge Manuel Santos; Jaime Dos Santos Cardoso; Paulo Noronha Lisboa-Filho
Journal:  Diagnostics (Basel)       Date:  2022-01-18

5.  Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®.

Authors:  Enrica Cavedo; Philippe Tran; Urielle Thoprakarn; Jean-Baptiste Martini; Antoine Movschin; Christine Delmaire; Florent Gariel; Damien Heidelberg; Nadya Pyatigorskaya; Sébastian Ströer; Pierre Krolak-Salmon; Francois Cotton; Clarisse Longo Dos Santos; Didier Dormont
Journal:  Eur Radiol       Date:  2022-01-01       Impact factor: 7.034

6.  Automatic segmentation of white matter hyperintensities: validation and comparison with state-of-the-art methods on both Multiple Sclerosis and elderly subjects.

Authors:  Philippe Tran; Urielle Thoprakarn; Emmanuelle Gourieux; Clarisse Longo Dos Santos; Enrica Cavedo; Nicolas Guizard; François Cotton; Pierre Krolak-Salmon; Christine Delmaire; Damien Heidelberg; Nadya Pyatigorskaya; Sébastian Ströer; Didier Dormont; Jean-Baptiste Martini; Marie Chupin
Journal:  Neuroimage Clin       Date:  2022-01-10       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.